Inhibrx
INBX
#5776
Rank
NZ$1.92 B
Marketcap
NZ$132.27
Share price
-3.60%
Change (1 day)
424.24%
Change (1 year)

Market capitalization of Inhibrx (INBX)

Market cap: NZ$1.92 Billion

As of December 2025 Inhibrx has a market cap of NZ$1.92 Billion. This makes Inhibrx the world's 5776th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Inhibrx from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$1.92 B399.31%
2024NZ$0.38 B-86.44%
2023NZ$2.84 B68.12%
2022NZ$1.69 B-30.35%
2021NZ$2.42 B40.82%
2020NZ$1.72 B

End of Day market cap according to different sources

On Dec 14th, 2025 the market cap of Inhibrx was reported to be:

NZ$1.99 Billion
by Nasdaq info icon info icon
NZ$1.99 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.56 B-18.46%๐Ÿ‡บ๐Ÿ‡ธ USA